Prophylactic amiodarone and lidocaine improve survival in an ovine model of large size myocardial infarction

Journal of Surgical Research

Volumn 185, Issue 1, 2013, Pages 152-158

  Li, Tieluo ^a   Wei, Xufeng ^a   Watkins, A Claire ^a   Sanchez, Pablo G ^a   Wu, Zhongjun J ^a   Griffith, Bartley P ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Amiodarone; Animal model; Arrhythmia; Lidocaine; Myocardial infarction; Ovine

Indexed keywords

ADRENALIN; AMIODARONE; LIDOCAINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL GAS; ARTICLE; CARDIOGENIC SHOCK; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG EFFICACY; HEART ARRHYTHMIA; HEART INFARCTION; HEART INFARCTION SIZE; HEART RATE; HEMODYNAMIC PARAMETERS; LOADING DRUG DOSE; MORTALITY; NONHUMAN; OVINE MODEL; PRIORITY JOURNAL; SURVIVAL RATE;

AMIODARONE; ANIMAL MODEL; ARRHYTHMIA; LIDOCAINE; MYOCARDIAL INFARCTION; OVINE;

AMIODARONE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; ATRIAL FIBRILLATION; DISEASE MODELS, ANIMAL; HEMODYNAMICS; LIDOCAINE; MORTALITY; MYOCARDIAL INFARCTION; SEVERITY OF ILLNESS INDEX; SHEEP, DOMESTIC; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 84886730096     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2013.05.050     Document Type: Article

References (19)

1. V.L. Roger, A.S. Go, and D.M. Lloyd-Jones Heart disease and stroke statistics-2011 update. A report from the American Heart Association Circulation 123 2011 e18
2. J.D. Schmitto, S.A. Mokashi, and L.S. Lee A novel, innovative ovine model of chronic ischemic cardiomyopathy induced by multiple coronary ligations Artif Organs 34 2010 918
3. K. Matsuzaki, M. Morita, and H. Hamamoto Elimination of ischemic mitral regurgitation does not alter long-term left ventricular remodeling in the ovine model Ann Thorac Surg 90 2010 788
4. S. Rabbani, H. Ahmdi, and E. Fayazzadeh Development of an ovine model of myocardial infarction Anz J Surg 78 2008 78
5. M. Regueiro-Purriños, F. Fernández-Vázquez, and A.P. Prado Ventricular arrhythmias and mortality associated with isoflurane and sevoflurane in a porcine model of myocardial infarction J Am Assoc Lab Anim Sci 55 2011 73
6. U. Häkkinen, J. Hartikainen, and M. Juntunen Analysing current trends in care of acute myocardial infarction using perfect data Ann Med 43 Suppl 1 2011 14
7. L. Laceya, and M. Tabberer Economic burden of post-acute myocardial infarction heart failure in the United Kingdom Eur J Heart Fail 7 2005 677
8. T.D. Szucs The growing healthcare burden of CHF J Renin Angiotensin Aldosterone Syst 1 Suppl 1 2000 2
9. J.A. Dixon, and F.G. Spinale Large animal models of heart failure, a critical link in the translation of basic science to clinical practice Circ Heart Fail 2 2009 262
10. H. Schwertz, U. Müller-Werdan, and R. Prondzinsky Catecholamine therapy in cardiogenic shock: helpful, useless or dangerous? Dtsch Med Wochenschr 129 2004 1925
11. B. Levy, P. Perez, and J. Perny Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock: a prospective, randomized pilot study Crit Care Med 39 2011 450
12. B.A. Weinberg, W.M. Miles, and L.S. Klein Five-year follow-up of 589 patients treated with amiodarone Am Heart J 125 1993 109
13. C. Sohns, and M. Zabel Current role of amiodarone in antiarrhythmic therapy Herzschrittmacherther Elektrophysiol 21 2010 239
14. R. Sassi, S. Cerutti, and K. Hnatkova HRV scaling exponent identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone IEEE Trans Biomed Eng 53 2006 103
15. M.G. Wyman, R.M. Wyman, and D.S. Cannom Prevention of primary ventricular fibrillation in acute myocardial infarction with prophylactic lidocaine Am J Cardiol 94 2004 545
16. S.R. Punnam, S.K. Goyal, and V.P. Kotaru Amiodarone - a "broad spectrum" antiarrhythmic drug Cardiovasc Hematol Disord Drug Targets 10 2010 73
17. P. Dorian, D. Cass, and B. Schwartz Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation N Engl J Med 346 2002 884
18. B. Rusche The 3Rs and animal welfare - conflict or the way forward? ALTEX 20 Suppl 1 2003 63
19. V. Baumans Use of animals in experimental research: an ethical dilemma Gene Ther 11 Suppl 1 2004 64